BAYN.DE - Bayer Aktiengesellschaft

XETRA - XETRA Delayed price. Currency in EUR
93.17
-0.22 (-0.24%)
At close: 5:35PM CEST
Stock chart is not supported by your current browser
Previous close93.39
Open93.15
Bid0.00 x 28400
Ask0.00 x 2100
Day's range93.15 - 93.97
52-week range87.40 - 118.04
Volume1,508,279
Avg. volume3,121,249
Market cap87.314B
Beta0.90
PE ratio (TTM)11.28
EPS (TTM)8.26
Earnings date5 Sep 2018
Forward dividend & yield2.76 (2.93%)
Ex-dividend date2018-05-28
1y target est120.99
  • Bayer's Bond Sale Targets Monsanto Acquisition Funds
    Bloomberg Video27 days ago

    Bayer's Bond Sale Targets Monsanto Acquisition Funds

    Jun.19 -- Bayer AG launched Europe's second-largest corporate bond sale this year, putting the company on track to complete a two-day, $21 billion fundraising drive to pay for the Monsanto Co. acquisition. Bloomberg's Molly Smith reports on "Bloomberg Daybreak: Americas."

  • Bayer, J&J Win Ruling That Upholds Patent for Xarelto Drug
    Bloomberg3 days ago

    Bayer, J&J Win Ruling That Upholds Patent for Xarelto Drug

    Bayer AG and Johnson & Johnson won a judge’s ruling that upheld the validity of a patent on the blood-thinning drug Xarelto and will keep Mylan NV from selling a generic, low-cost version until August 2024, when the patent expires. Mylan NV and Sigmapharm Laboratories LLC failed to prove the patent shouldn’t have been issued, U.S. District Court Judge Lawrence Stengel in Wilmington, Delaware, said. The companies can’t sell their generic versions of the drug until the patent expires, the judge said in a separate order.

  • U.S. judge allows lawsuits over Monsanto's Roundup to proceed to trial
    Reuters6 days ago

    U.S. judge allows lawsuits over Monsanto's Roundup to proceed to trial

    The decision by U.S. District Judge Vince Chhabria in San Francisco followed years of litigation and weeks of hearings about the controversial science surrounding the safety of the chemical glyphosate, the key ingredient in Monsanto's top-selling weed-killer. Monsanto is now a unit of Bayer AG (BAYGn.DE), following a $62.5 billion takeover of the U.S. seed major which closed in June. The U.S. Environmental Protection Agency last September concluded glyphosate is likely not carcinogenic to humans.

  • Reuters6 days ago

    U.S. judge allows lawsuits over Monsanto's Roundup to proceed to trial

    The decision by U.S. District Judge Vince Chhabria in San Francisco, California, followed years of litigation and weeks of hearings about the controversial science surrounding the safety of the chemical glyphosate, the key ingredient in Monsanto's top-selling weed-killer. Monsanto is a unit of Bayer AG (BAYGn.DE), following the $62.5 billion takeover of the U.S. seed major which wrapped up in June.

  • Monsanto Judge Won't Block Cancer Victims' Key Witnesses
    Bloomberg6 days ago

    Monsanto Judge Won't Block Cancer Victims' Key Witnesses

    Monsanto Co. lost a court ruling that permits key witnesses to testify in a lawsuit claiming the company’s Roundup weed killer caused cancer for farmers and other users. It’s a significant victory for the cancer victims, who need expert testimony to advance more than 300 suits in San Francisco federal court seeking to hold Monsanto liable for failing to warn consumers about the risk of using the weed killer. A jury trial hasn’t been scheduled, but the decision puts pressure on Monsanto to settle the cases.

  • Monsanto may appeal Brazil royalties ruling
    Reuters6 days ago

    Monsanto may appeal Brazil royalties ruling

    Monsanto Co is considering appealing a Brazilian court ruling obliging it to deposit in an escrow account the royalties related to its Intacta RR2 Pro soy seed biotechnology, the company said in a statement on Tuesday. "Monsanto is weighing options for appealing (the ruling) and will take all measures to protect its legal rights," the statement said. Last week, a Brazilian judge ordered units of Monsanto Co to deposit the royalties related to that genetically modified seed in an escrow account pending the outcome of litigation over a patent dispute between Brazilian soy growers and the U.S. seeds company, now a unit of Bayer AG.

  • Reuters12 days ago

    Brazil judge orders Monsanto to deposit royalties related to GMO seed

    A Brazilian judge has ordered local units of Monsanto Co to put royalties related to a GMO soy seed technology in an escrow account, in a decision likely to hinder the U.S. seed company's ability to collect royalties from the business. The July 3 ruling relates to a patent dispute between Brazilian soy growers in the state of Mato Grosso and Monsanto, which was recently acquired by Germany's Bayer AG in a 63 billion-euro deal. The judge ordered local units of Monsanto to deposit in an escrow account royalties related to the Intacta RR2 Pro genetically modified soy seed technology pending the end of the patent litigation, according to the decision seen by Reuters.

  • Covestro CEO Sweeps Away Bayer Culture With Workforce Overhaul
    Bloomberg12 days ago

    Covestro CEO Sweeps Away Bayer Culture With Workforce Overhaul

    German chemicalmaker Covestro AG took a financial leap forward after separating from Bayer AG three years ago. Chief Executive Officer Markus Steilemann says it’s now time to make a cultural split.

  • Reuters13 days ago

    Bayer sees Brazil as key growth driver for global crop division

    SAO PAULO (Reuters) - Brazil is the second most important market for Germany's Bayer AG (BAYGn.DE) and will be a growth driver for its crop science division, global crop science chief executive officer ...

  • Does Monsanto Company’s (NYSE:MON) Debt Level Pose A Problem?
    Simply Wall St.20 days ago

    Does Monsanto Company’s (NYSE:MON) Debt Level Pose A Problem?

    Investors seeking to preserve capital in a volatile environment might consider large-cap stocks such as Monsanto Company (NYSE:MON) a safer option. Risk-averse investors who are attracted to diversified streams ofRead More...

  • The Wall Street Journal24 days ago

    [$$] Life After the Monsanto Sale

    After nearly 40 years at Monsanto Co., the company that spread genetically engineered seed across the U.S. heartland and beyond, now-former chief executive Hugh Grant doesn’t know exactly what’s next, aside from a desire to stay in agriculture. Mr. Grant earlier this month oversaw the sale of his former employer to Bayer AG, a more-than-$60 billion deal that has reordered the global agricultural industry. The German drug and chemical conglomerate now is the world’s biggest supplier of crop seeds and pesticides to farmers, acquiring the top global franchise in biotech seeds engineered to survive chemical sprays and repel destructive bugs—products pioneered by Monsanto that have transformed American agriculture.

  • Is Bayer Aktiengesellschaft’s (FRA:BAYN) Balance Sheet Strong Enough To Weather A Storm?
    Simply Wall St.24 days ago

    Is Bayer Aktiengesellschaft’s (FRA:BAYN) Balance Sheet Strong Enough To Weather A Storm?

    Investors pursuing a solid, dependable stock investment can often be led to Bayer Aktiengesellschaft (FRA:BAYN), a large-cap worth €85.95b. Risk-averse investors who are attracted to diversified streams of revenue andRead More...

  • Bloomberg27 days ago

    Finding Cancer Patients Is Pharma Industry's Unlikely Challenge

    The world’s biggest pharmaceutical companies, looking to sell a new type of cancer drug that could transform treatment, are grappling with an unusual challenge: finding patients. The new medicines aim to shrink tumors by targeting a rare genetic anomaly -- appearing in 1,500 to 5,000 patients’ tumors in the U.S. annually -- that can spur cancer’s growth. Bayer AG is out in front with a drug that could go on sale by the end of the year.

  • EQS Group27 days ago

    Bayer Aktiengesellschaft: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

    Bayer Aktiengesellschaft / Total Voting Rights Announcement19.06.2018 / 17:33 Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Publication of total number of voting rights1. Details of issuerBayer AktiengesellschaftKaiser-Wilhelm-Allee 151373 LeverkusenGermany2. Type of capital measure Type of capital measureDate of status / date of effect Conditional capital increase (Sec. 41 para. 2 WpHG)XOther capital measure (Sec. 41 para. 1 WpHG)19 Jun 20183. ...

  • Bayer's Bond Sale Targets Monsanto Acquisition Funds
    Bloomberg27 days ago

    Bayer's Bond Sale Targets Monsanto Acquisition Funds

    Bayer AG launched Europe's second-largest corporate bond sale this year, putting the company on track to complete a two-day, $21 billion fundraising drive to pay for the Monsanto Co. acquisition. Bloomberg's ...

  • $21 Billion Shows Two Bond Markets Aren't Equal
    Bloomberg27 days ago

    $21 Billion Shows Two Bond Markets Aren't Equal

    Bayer AG is finding it harder to sell debt in its home country than in the U.S., a telling sign of the respective health of the euro and dollar credit markets. The German chemical giant wanted to complete the financing for its $63 billion acquisition of Monsanto Co. — but it had to pay up to do that in Europe. Once the new issue premium — the extra yield investors are offered to buy the new securities over existing ones of a comparable maturity — was reduced by the underwriters, the bonds were eventually priced close to where Bayer's existing bonds are trading.

  • Bayer’s Bond Puts the Fed in Its Place
    Bloomberg28 days ago

    Bayer’s Bond Puts the Fed in Its Place

    German chemical giant Bayer AG has finally launched one of the biggest corporate bond sales of the year. This is an important test of the health of the market, given the Federal Reserve’s move last week to raise rates and stoke expectations for additional tightening.

  • Monsanto Faces Man Dying of Cancer in Roundup Trial
    Bloomberg28 days ago

    Monsanto Faces Man Dying of Cancer in Roundup Trial

    Lee Johnson’s doctors didn’t think he’d live long enough to testify in court that exposure to Monsanto Co.’s Roundup weed killer caused his deadly cancer. As groundskeeper for the school district in Benicia, California, about 40 miles east of San Francisco, Johnson mixed and sprayed hundreds of gallons of Roundup. Glyphosate, the main ingredient in Roundup, was first approved for use in Monsanto’s weed killer in 1974.

  • Should Bayer Aktiengesellschaft’s (FRA:BAYN) Recent Earnings Decline Worry You?
    Simply Wall St.last month

    Should Bayer Aktiengesellschaft’s (FRA:BAYN) Recent Earnings Decline Worry You?

    Examining Bayer Aktiengesellschaft’s (DB:BAYN) past track record of performance is a valuable exercise for investors. It enables us to understand whether the company has met or exceed expectations, which isRead More...

  • Warren Buffett's Cash "Problem" Just Got $2.4 Billion Worse
    Motley Foollast month

    Warren Buffett's Cash "Problem" Just Got $2.4 Billion Worse

    Thanks to a big merger that just closed, Berkshire Hathaway’s stockpile of cash is getting even bigger.

  • Germany's Bayer closes $63 billion Monsanto takeover, plans to drop US company's name
    CNBClast month

    Germany's Bayer closes $63 billion Monsanto takeover, plans to drop US company's name

    German conglomerate Bayer on Thursday closed its $63 billion merger with St. Louis-based agribusiness giant Monsanto and plans to drop the U.S. company's name.

  • Business Insider UKlast month

    Germany's Bayer completes purchase of Monsanto

    BERLIN (AP) — German pharmaceutical company Bayer AG says it has completed its purchase of U.S. seed and weed-killer maker Monsanto Co.

  • Business Insider UKlast month

    Germany's Bayer completes purchase of Monsanto

    BERLIN (AP) — German pharmaceutical company Bayer AG says it has completed its purchase of U.S. seed and weed-killer maker Monsanto Co.

  • Bayer Closes Monsanto Deal to Cap $63 Billion Transformation
    Bloomberglast month

    Bayer Closes Monsanto Deal to Cap $63 Billion Transformation

    Bayer AG closed its $63 billion acquisition of Monsanto Co., emerging from an arduous two-year antitrust review as the biggest seed and agricultural chemicals maker in the world. Integration should begin in about two months, once the sale of some of Bayer’s agriculture assets to BASF SE is complete. The transaction, which will double the size of Bayer’s agriculture business, means “we will be even better placed to help the world’s farmers grow more healthy and affordable food in a sustainable manner,” Bayer Chairman Werner Baumann said in a statement on Thursday.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes